Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Saved in:
| Title: | Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. |
|---|---|
| Authors: | Desai AV; Department of Pediatrics, University of Chicago, Chicago, Illinois., Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, Illinois., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Oppong A; Pritzker School of Medicine, University of Chicago, Chicago, Illinois., Yuan C; Department of Radiology, University of Chicago, Chicago, Illinois., Berg KR; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania., MacQuarrie K; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois., Sokol E; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois., Hall AG; Seattle Children's Hospital and University of Washington, Seattle, Washington., Pinto N; Seattle Children's Hospital and University of Washington, Seattle, Washington., Wolfe I; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan., Mody R; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Smith V; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas., Foster JH; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas., Nassin M; Department of Pediatrics, University of Chicago, Chicago, Illinois., LaBelle JL; Department of Pediatrics, University of Chicago, Chicago, Illinois., Bagatell R; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania., Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois. |
| Source: | Cancer [Cancer] 2022 Aug 01; Vol. 128 (15), pp. 2967-2977. Date of Electronic Publication: 2022 Jun 06. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35665495 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Desai+AV%22">Desai AV</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Applebaum+MA%22">Applebaum MA</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Karrison+TG%22">Karrison TG</searchLink>; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Oppong+A%22">Oppong A</searchLink>; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Yuan+C%22">Yuan C</searchLink>; Department of Radiology, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Berg+KR%22">Berg KR</searchLink>; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22MacQuarrie+K%22">MacQuarrie K</searchLink>; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Sokol+E%22">Sokol E</searchLink>; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Hall+AG%22">Hall AG</searchLink>; Seattle Children's Hospital and University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Pinto+N%22">Pinto N</searchLink>; Seattle Children's Hospital and University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Wolfe+I%22">Wolfe I</searchLink>; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Mody+R%22">Mody R</searchLink>; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Shusterman+S%22">Shusterman S</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Smith+V%22">Smith V</searchLink>; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Foster+JH%22">Foster JH</searchLink>; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Nassin+M%22">Nassin M</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22LaBelle+JL%22">LaBelle JL</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Bagatell+R%22">Bagatell R</searchLink>; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Cohn+SL%22">Cohn SL</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2022 Aug 01; Vol. 128 (15), pp. 2967-2977. <i>Date of Electronic Publication: </i>2022 Jun 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35665495 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.34263 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2967 Titles: – TitleFull: Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Desai AV – PersonEntity: Name: NameFull: Applebaum MA – PersonEntity: Name: NameFull: Karrison TG – PersonEntity: Name: NameFull: Oppong A – PersonEntity: Name: NameFull: Yuan C – PersonEntity: Name: NameFull: Berg KR – PersonEntity: Name: NameFull: MacQuarrie K – PersonEntity: Name: NameFull: Sokol E – PersonEntity: Name: NameFull: Hall AG – PersonEntity: Name: NameFull: Pinto N – PersonEntity: Name: NameFull: Wolfe I – PersonEntity: Name: NameFull: Mody R – PersonEntity: Name: NameFull: Shusterman S – PersonEntity: Name: NameFull: Smith V – PersonEntity: Name: NameFull: Foster JH – PersonEntity: Name: NameFull: Nassin M – PersonEntity: Name: NameFull: LaBelle JL – PersonEntity: Name: NameFull: Bagatell R – PersonEntity: Name: NameFull: Cohn SL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug 01 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 128 – Type: issue Value: 15 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |